Welcome to our dedicated page for National Research Corporation news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Research Corporation stock.
National Research Corporation Common Stock (Delaware) (symbol: NRC) is dedicated to enhancing the experiences of patients, residents, and healthcare providers for over 35 years. Operating primarily in the United States and Canada, NRC Health provides analytics and insights that help healthcare organizations measure and improve patient and employee experiences, fostering greater engagement and loyalty.
NRC Health's offerings include a wide range of solutions that deliver value to its clients by enabling a deeper understanding of the individuals they serve. This holistic approach includes proprietary methods and tools that aid healthcare systems in designing experiences that build trust and inspire loyalty. These solutions are critical for healthcare providers, payers, and other organizations aiming to improve care delivery and patient outcomes.
In recent developments, NRC Health has partnered with LifeBridge Health, one of Maryland’s largest health systems, to implement the Human Understanding® program. This partnership, highlighted by NRC Health’s comprehensive data-driven insights and personalized healthcare solutions, aims to enhance patient care and satisfaction through innovative, human-centered approaches. The collaboration also involves administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey to ensure consistent quality measures.
Financially, NRC Health remains robust, drawing significant revenue from its United States operations. Its focused market research, patient-centered initiatives, and consumer preference data have earned NRC Health a top ranking for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information about NRC Health, their services, or recent updates, visit www.nrchealth.com. You can also contact them at 800-388-4264 or via email at info@nrchealth.com.
NRC Health announced a quarterly cash dividend of $0.24 per share payable on July 15, 2022, to shareholders on record by June 30, 2022. Additionally, the Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares. This buyback will occur based on market conditions and corporate considerations. The previous repurchase authorization has concluded, and the new one has no expiration date, reflecting NRC Health's commitment to enhancing shareholder value.
NRC Health has appointed Parul Bhandari, a Microsoft executive, to its Board of Directors as of May 19, 2022. Bhandari brings over 20 years of experience in technology and digital transformation, focusing on leveraging data and AI for healthcare improvement. Her role will enhance NRC's mission to foster Human Understanding in healthcare. With a solid background in business development and strategy, Bhandari aims to address the challenges of balancing technology with human-centric care delivery.
National Research Corporation (NASDAQ:NRC) reported an 8% revenue increase in Q1 2022, reaching $38.4 million compared to $35.5 million in Q1 2021. However, operating income fell by 3% to $11.7 million, and net income decreased to $8.5 million from $9.2 million year-over-year. Diluted earnings per share dropped to $0.34, down from $0.36. The company is focused on organic growth, enhancing core offerings like the Human Understanding Program, while also investing in innovation and employee benefits. Cash flow from operations decreased to $8.3 million, but net cash rose to $21.8 million.
NRC Health (NASDAQ:NRC) will host a first quarter earnings conference call on May 4, 2022, following the release of financial results after market close on May 3, 2022. The conference call will start at 11:00 a.m. ET and will be available via a live audio webcast. A replay will be accessible for 30 days after the event. NRC Health has been dedicated to enhancing human understanding in healthcare for over 40 years, focusing on improving key experiences that build trust between healthcare organizations and their clients.
NRC Health released its 2022 Pediatric Consumer Trends Report, highlighting the evolving needs of pediatric consumers post-COVID. Key findings indicate a 135% increase in parents resuming healthcare services since 2020, a 5.2% rise in telehealth adoption, and a 163% surge in mental health hospitalizations among youth. Despite these trends, pediatric marketing recall remains stagnant at 1.5%, and the Net Promoter Score for pediatric services has declined from 69 in April 2020 to 53 in December 2021. The report underscores the importance of addressing these challenges in pediatric healthcare.
NRC Health announced a quarterly cash dividend of $0.24 per share, payable on April 15, 2022. Shareholders of record as of March 31, 2022 will receive this dividend. NRC Health, a leader in analytics and insights for over 40 years, focuses on measurement and enhancement of Human Understanding.
National Research Corporation (NASDAQ:NRC) reported strong Q4 2021 results, with a 10% revenue increase to $38.3 million and a 26% operating income rise to $12.9 million, resulting in an operating margin of 34%. For the full year, revenue was $148.0 million (+11%) and operating income was $50.3 million (+18%). Diluted EPS increased to $0.38 in Q4 and $1.46 for the year. The launch of the Human Understanding Program aims to enhance personalized care across healthcare systems. The company's cash flow from operations grew to $46.3 million, boosting net cash to $27.8 million.
National Research Corporation (NASDAQ:NRC) will host a web simulcast for its 2021 fourth quarter earnings conference call on February 9, 2022, at 11:00 a.m. ET. The earnings results will be disclosed after market close on February 8, 2022. A replay of the live broadcast will be available for 30 days following the event. For over 40 years, NRC has been a leader in providing analytics and insights to enhance patient and employee experiences, aiming to improve customer engagement and loyalty in the healthcare sector.
National Research Corporation (NASDAQ:NRC) announced a quarterly cash dividend of $0.12 per share, payable on January 14, 2022. Shareholders recorded by the close of business on December 30, 2021 will qualify for this payment. The corporation has been a prominent provider of analytics and insights aimed at enhancing human understanding for over 40 years.
FAQ
What is the current stock price of National Research Corporation (NRC)?
What is the market cap of National Research Corporation (NRC)?
What services does NRC Health provide?
Where does NRC Health operate?
What is the Human Understanding® program?
Who are NRC Health's recent partners?
What is the CAHPS survey?
How long has NRC Health been in operation?
What distinguishes NRC Health in the market?
How can I contact NRC Health?
What type of organizations benefit from NRC Health's services?
How does NRC Health support healthcare organizations?
